pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Preclinical
RT-002
Sarcopenia
Ridgeline Therapeutics LLC
Phase 2
RT-100
Systolic Heart Failure (HFrEF)
Renova Therapeutics Inc
Preclinical
RT-200
Type 2 Diabetes
Renova Therapeutics Inc
Phase 1
← prev
page 150 of 271
next →
Pain
89
Neurology
1
RTT-1
Rett Syndrome
Grann Pharmaceuticals Inc
Phase 3
RTX-015
Retinitis Pigmentosa (Retinitis)
Ray Therapeutics Inc
RUBRACA
RUBRACA (RUCAPARIB CAMSYLATE)
no indication
pharmaand GmbH
RUXIENCE
RUXIENCE (RITUXIMAB-PVVR)
no indication
$PFE
PFIZER INC
Phase 2
RV-01
Castration-Resistant Prostate Cancer (CRPC)
Radiopharm Ventures LLC
Phase 1
RV-1770
Respiratory Syncytial Virus (RSV) Infections
Hualan Biological Vaccine Inc
Preclinical
RVB-001
Netherton Syndrome (Bamboo Hair)
ResVita Bio Inc
Preclinical
RVB-003
Netherton Syndrome (Bamboo Hair)
ResVita Bio Inc
Phase 2
RX-0301
Hepatocellular Carcinoma
Zhejiang Haichang Biotechnology Co Ltd
Phase 2
RXRG-001
Xerostomia
RiboX (Shanghai) Therapeutics Co Ltd
Phase 2
RY-104
Wet (Neovascular / Exudative) Macular Degeneration
Neuracle Genetics Inc
RYBREVANT
RYBREVANT (AMIVANTAMAB-VMJW)
no indication
Janssen Biotech Inc
RYBREVANT FASPRO
RYBREVANT FASPRO (AMIVANTAMAB AND HYALURONIDASE-LPUJ)
no indication
Janssen Biotech Inc
RYSTIGGO
RYSTIGGO (ROZANOLIXIZUMAB-NOLI)
no indication
UCB SA
RYTELO
RYTELO (IMETELSTAT SODIUM)
1. INDICATIONS AND USAGE RYTELO is indicated for the trea…
$GERN
GERON CORP
Phase 2
RZ-001
Glioblastoma Multiforme (GBM)
Rznomics Inc
Marketed
Radicava
Radicava (edaravone)
Amyotrophic Lateral Sclerosis
$SGIOF
SHIONOGI & CO LTD
Phase 2
Radspherin
Colorectal Cancer
Oncoinvent ASA
Preclinical
Rare Disease
Unspecified Rare Disease
Dawn Sea Therapeutics
Phase 3
ReNu
Osteoarthritis
$ORGO
Organogenesis Holdings Inc.
Preclinical
Recombinant AAT
Charcot-Marie-Tooth Disease Type I A
Ageronix SA
Preclinical
Recombinant Alpha-1 Antitrypsin Replacement for Alpha-1 Antitrypsin Deficiency
Alpha-1 Antitrypsin Deficiency (A1AD)
Caravella Biopharma SA
Preclinical
Recombinant Human Neuroglobin (rNgb)
Carbon Monooxide Poisoning
Globin Solutions Inc
Preclinical
Recombinant Peptide to Inhibit Type I Collagen for Frozen Shoulder Syndrome
Frozen Shoulder Syndrome
Ortholevo Inc
Preclinical
Recombinant Protein to Activate p38 MAP Kinase for Round Worm Infections
Nematodal (Round Worm) Infections
University of California San Diego
Preclinical
Recombinant Protein to Antagonize TGF beta for Immunology, Dermatology, Gastrointestinal and Musculoskeletal Disorders
Oral Mucositis
Allander Biotechnologies LLC
Marketed
Regenecyte
Regenecyte
Blood Cancer
StemCyte Inc
